<DOC>
	<DOC>NCT01670851</DOC>
	<brief_summary>This is a prospective, multicenter, single arm, observational pilot study to assess the clinical outcomes of Strattice Reconstructive Tissue Matrix for perineal reconstruction following eLAPE and simultaneous stoma reinforcement.</brief_summary>
	<brief_title>Perineal Reconstruction Following eLAPE and Simultaneous Stoma Sublay Reinforcement</brief_title>
	<detailed_description>About 40 subjects will be enrolled from 4 centers over approx 24 months. Subjects will all be undergoing extralevator abdominoperineal excision with concomitant ostomy creation.</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>Primary cancers undergoing curative surgery (R0) Life expectancy &gt; 2 yrs Neoadjuvant radiotherapy with or without chemotherapy Pelvic extenteration or extended resections Previously irradiated patients (i.e. radiation therapy for a previous cancer) Comorbidities of: systemic infection, chronic liver failure, chronic renal failure, HIV, Hepatitis C, other advanced/metastatic cancer, collagen disorder sensitivity to porcine derived products or polysorbate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>eLAPE,</keyword>
	<keyword>perineum,</keyword>
	<keyword>pelvic floor reconstruction</keyword>
</DOC>